Enterprise

One standard for every train, in every site.

For pharma networks and CDMOs running dozens of trains across continents: one control plane, one validation posture, one set of models that improve everywhere as each site corrects them.

$600k+typical land ACV
134%NRR target
24/7plant-edge operation

Enterprise

Built for multi-site pharma and CDMO networks

Multi-site deployment, plant-edge fleet management, custom route and crystallization models, validation support, and on-prem or hybrid installation with NVIDIA AI Enterprise.

Fleet of plant edges

Manage models, autonomy levels, and versions across every train in every site from one control plane.

Validation package

Qualification documentation, model version locks, and change-control artifacts your quality unit can review.

Outcome-linked pricing

Enterprise agreements can tie a component of fees to polymorph consistency, yield, or reprocessing reduction.

Dedicated engineering

Solutions engineers who speak crystallization, PAT, and GMP — not just software.

Fleet

Manage autonomy the way you manage recipes

A single control plane shows every plant-edge node, the model version it is running, its autonomy level, and its performance against the site baseline — with promotion and rollback under change control.

  • Per-train autonomy configuration and audit
  • Staged model promotion with shadow evaluation
  • Cross-site performance benchmarking (opt-in)
  • Central evidence export for inspections

Deployment

On-prem, hybrid, or air-gapped

Deploy on NVIDIA AI Enterprise inside your own infrastructure, or let us run the training and fleet plane while inference stays entirely at your plants. Your routes never leave your boundary.

  • NVIDIA AI Enterprise supported deployment
  • Air-gapped installations with offline model bundles
  • Regional data residency for multinational networks

Engagement

How an enterprise rollout runs

Land narrow, prove the number, then expand under a network agreement.

  1. Weeks 0–4

    Plant review & scoping

    Walk the train, map the tag list and PAT stack, agree the pilot metric with manufacturing and quality.

  2. Weeks 4–12

    Shadow campaign

    Polymorra perceives and predicts alongside your chemists. Baseline and model performance established.

  3. Quarter 2

    Assist mode

    Recommendations approved by chemists. Corrections train the site model. Validation package assembled.

  4. Quarter 3+

    Bounded autonomy & expansion

    Qualified trains move to auto-control; the agreement expands to further trains and sites.

Accelerated computing

An NVIDIA-accelerated stack, from the train to the fleet

Perception at the edge, reasoning in the cloud, and a reactor-and-crystallizer twin in between.

Stack

Jetson at the train

Plant-edge inference per reactor or crystallizer train: PVM crystal-image models, FBRM feature extraction, Raman and NIR soft sensors, anomaly and safety classifiers. [ASPIRATIONAL]

Stack

TensorRT + Holoscan

Low-latency perception and sensor-stream preprocessing for in-situ imaging and PAT spectra inside validated control windows.

Stack

Triton + NIM

Route-specific polymorph, impurity, particle-size, endpoint, and batch-reasoning models served with validated version locks and rollback.

Stack

Omniverse + Cosmos

Reactor-and-crystallizer twin plus synthesis of rare crystallization faults — oiling-out, fouling, seed drift, wrong-polymorph nucleation. [ASPIRATIONAL]

Stack

RAPIDS + cuOpt

Telemetry ETL at campaign scale, plus scheduling, solvent recovery, and crystallization-profile optimization.

Stack

NeMo + DGX

Fine-tuned chemistry-process and batch-record reasoning trained on de-identified design-partner data and chemist corrections. [ASPIRATIONAL]

Plant-edge console

One screen for the batch that is running right now

Supersaturation, particle size distribution, predicted polymorph, impurity trajectory, and the next control move — with the evidence behind each number.

Polymorra plant-edge console showing live supersaturation, particle size distribution, predicted polymorphic form, and impurity trajectory for a running crystallization, with the recommended next control move.

Integrations

Connects to the systems already running your plant

Polymorra reads and writes through the reactor DCS, PAT instruments, crystallizer and isolation skids, historians, and MES you already validated.

Reactor control & DCS

Emerson DeltaVSiemens PCS 7Honeywell ExperionOPC UAModbus/TCP

PAT & analytics

Mettler-Toledo FBRMPVM in-situ imagingReactIREndress+Hauser RamanNIRHPLC / XRPD imports

Isolation & drying

Nutsche filter-dryersCentrifugesAgitated dryersConical millsMicronizers

MES, historian & quality

Körber PAS-XEmerson SyncadeOSIsoft PILIMSeBR / QMS exports

Trust & compliance

Validated for GMP manufacturing

Polymorra is engineered for regulated drug-substance production: grounded outputs, immutable audit trails, graduated autonomy, and validation documentation from day one.

21 CFR Part 11

Immutable, validated audit log for every agent perception, recommendation, and control action, with e-signature-ready review flows.

GMP / ICH Q7

Change control, validated model versioning, and deployment documentation designed for drug-substance manufacturing.

SOC 2

SOC 2 Type I in progress, Type II on the roadmap; SSO/RBAC, encryption in transit and at rest. [ASPIRATIONAL]

Route & IP protection

Per-tenant isolation of routes, recipes, spectra, and crystal images. No cross-tenant training. On-prem option.

Graduated autonomy

Shadow → assist → bounded auto-control. Every autonomy level is explicitly configured, bounded, and revocable.

Grounded outputs

Every recommendation cites the spectra, images, telemetry, SOP, or specification it was derived from.

Plant-edge first

Inference runs on-site so control loops survive network loss; cloud is for training, fleet, and analytics.

Human-in-the-loop

Chemist and QA checkpoints are first-class: approve, correct, or reject — and every correction trains the models.

Voices from the plant

What operators say

Composite quotes from design-partner discovery interviews. [PLACEHOLDER — to be replaced with named references post-pilot]

“The crystallization step is where our campaigns live or die. Seeing supersaturation, particle size, and predicted polymorph in one place — and having the profile adjust itself — is what we have wanted for twenty years.”
Crystallization & PAT EngineerTop-20 branded pharma · API site
“We do not want another dashboard. We want the batch to come out right and the record to be reviewable by exception. That is the only pitch that gets past QA.”
QA / Regulatory ManagerGeneric API manufacturer
“Tech transfer is our bottleneck. If the twin can predict the plant crystal from the lab crystal, that is worth more than the software costs.”
API Manufacturing DirectorGlobal CDMO

Pricing

Land on one train. Expand to the plant.

Pricing follows the value of the batch: per reactor or crystallizer train, per plant, or an enterprise agreement with outcome components.

Line

Manufacturers validating ROI on the wedge workflow.

$13,000

per reactor or crystallizer train / month

  • Reaction-control, crystallization/polymorph-control, or PAT-sensing AI for one train
  • Plant-edge runtime with validated model versioning
  • Connectors for one DCS, one PAT stack, and one MES
  • Review console for chemists and PAT engineers
  • Part 11 audit trail from day one
Start a line pilot

Enterprise

CDMOs and pharma networks standardizing on Polymorra.

Custom

land $600k – $7M ACV

  • Multi-site deployment and plant-edge fleet management
  • Custom route, crystallization, and impurity models
  • Validation support and qualification documentation
  • On-prem or hybrid deployment with NVIDIA AI Enterprise
  • SLAs, dedicated solutions engineering, and outcome pricing
Talk to sales

Standardize the hardest step in your network.

Start with one crystallizer or reactor train. Prove polymorph, yield, and reprocessing ROI in a validation-friendly pilot. Then expand across the plant.